GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 72 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44,313 | +33.3% | 23,080 | 0.0% | 0.00% | – |
| Q2 2023 | $33,235 | -31.4% | 23,080 | +0.0% | 0.00% | – |
| Q1 2023 | $48,466 | +85.8% | 23,079 | 0.0% | 0.00% | – |
| Q4 2022 | $26,079 | -31.4% | 23,079 | 0.0% | 0.00% | – |
| Q3 2022 | $38,000 | +26.7% | 23,079 | 0.0% | 0.00% | – |
| Q2 2022 | $30,000 | -18.9% | 23,079 | 0.0% | 0.00% | – |
| Q1 2022 | $37,000 | -22.9% | 23,079 | 0.0% | 0.00% | – |
| Q4 2021 | $48,000 | -46.7% | 23,079 | 0.0% | 0.00% | – |
| Q3 2021 | $90,000 | +21.6% | 23,079 | -0.0% | 0.00% | – |
| Q2 2021 | $74,000 | -65.7% | 23,080 | -76.9% | 0.00% | – |
| Q1 2021 | $216,000 | -10.4% | 99,901 | -7.0% | 0.00% | – |
| Q4 2020 | $241,000 | -18.6% | 107,410 | -3.0% | 0.00% | – |
| Q3 2020 | $296,000 | -14.0% | 110,771 | -1.7% | 0.00% | – |
| Q2 2020 | $344,000 | +53.6% | 112,632 | -1.5% | 0.00% | – |
| Q1 2020 | $224,000 | -31.5% | 114,390 | +0.0% | 0.00% | – |
| Q4 2019 | $327,000 | -21.0% | 114,389 | +1.5% | 0.00% | – |
| Q3 2019 | $414,000 | +4.8% | 112,741 | +18.3% | 0.00% | – |
| Q2 2019 | $395,000 | +299.0% | 95,315 | +392.5% | 0.00% | – |
| Q1 2019 | $99,000 | +45.6% | 19,352 | -2.9% | 0.00% | – |
| Q4 2018 | $68,000 | -43.3% | 19,930 | 0.0% | 0.00% | – |
| Q3 2018 | $120,000 | -5.5% | 19,930 | -0.0% | 0.00% | – |
| Q2 2018 | $127,000 | +4.1% | 19,931 | -22.8% | 0.00% | – |
| Q1 2018 | $122,000 | +82.1% | 25,809 | +29.5% | 0.00% | – |
| Q4 2017 | $67,000 | +39.6% | 19,930 | -9.9% | 0.00% | – |
| Q3 2017 | $48,000 | -5.9% | 22,121 | +6.4% | 0.00% | – |
| Q2 2017 | $51,000 | +6.2% | 20,798 | +0.6% | 0.00% | – |
| Q1 2017 | $48,000 | +118.2% | 20,677 | -5.8% | 0.00% | – |
| Q4 2016 | $22,000 | -8.3% | 21,950 | +3.7% | 0.00% | – |
| Q3 2016 | $24,000 | -33.3% | 21,171 | -14.7% | 0.00% | – |
| Q2 2016 | $36,000 | +2.9% | 24,811 | +0.3% | 0.00% | – |
| Q1 2016 | $35,000 | -14.6% | 24,727 | 0.0% | 0.00% | – |
| Q4 2015 | $41,000 | -29.3% | 24,727 | 0.0% | 0.00% | – |
| Q3 2015 | $58,000 | -14.7% | 24,727 | -0.3% | 0.00% | – |
| Q2 2015 | $68,000 | -73.3% | 24,807 | -67.4% | 0.00% | – |
| Q1 2015 | $255,000 | -9.6% | 76,086 | -6.3% | 0.00% | – |
| Q4 2014 | $282,000 | -33.0% | 81,192 | -3.0% | 0.00% | – |
| Q3 2014 | $421,000 | -80.3% | 83,712 | -45.8% | 0.00% | – |
| Q2 2014 | $2,134,000 | +560.7% | 154,540 | +631.8% | 0.00% | – |
| Q1 2014 | $323,000 | +88.9% | 21,117 | 0.0% | 0.00% | – |
| Q4 2013 | $171,000 | – | 21,117 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |